Abstract
This study aims to analyze the outcome of patients with stage IIIA-N2 non–small-cell lung cancer who underwent pneumonectomy to prove its safety and feasibility, in particular after induction chemotherapy. Based on the acceptable morbidity and mortality rate and the long-term survival, pneumonectomy should not be excluded for selected patients as a matter of principle.
Original language | English |
---|---|
Pages (from-to) | 97-106.e1 |
Journal | Clinical Lung Cancer |
Volume | 20 |
Issue number | 2 |
DOIs | |
Publication status | Published - Mar 2019 |
Keywords
- Advanced stage
- Induction therapy
- Lung cancer
- Short and long term outcomes
- Surgery
ASJC Scopus subject areas
- Oncology
- Pulmonary and Respiratory Medicine
- Cancer Research